La taille du marché des dispositifs d'administration de médicaments sans aiguille devrait atteindre 28,42 milliards de dollars américains d'ici 2031, contre 14,76 milliards de dollars américains en 2023. Le marché devrait enregistrer un TCAC de 8,5 % en 2024-2031. L'augmentation des initiatives stratégiques et l'utilisation de logiciels d'intégration des soins de santé resteront probablement les principales tendances du marché des dispositifs d'administration de médicaments sans aiguille.
< span>Dispositifs d'administration de médicaments sans aiguille Analyse du marché
Les aiguilles peuvent entraîner diverses maladies, telles que le VIH, et blessures s’il n’est pas administré avec les précautions appropriées. Selon l'article « MEDICSEN : NEEDLE-FREE SMARTPATCH FOR PAINLESS MEDICAMENT DELIVERY », plus de 2 000 personnes aux États-Unis sont touchées chaque jour par des blessures par piqûre d'aiguille, générant plus de 3 milliards de dollars de coûts associés chaque année. L’utilisation de dispositifs d’administration de médicaments sans aiguille réduit les risques de blessures et de maladies. Ainsi, une augmentation de la prévalence des blessures par piqûre d’aiguille et une augmentation des dépenses de traitement alimentent la croissance du marché des dispositifs d’administration de médicaments sans aiguille.
Dispositifs d’administration de médicaments sans aiguille. Aperçu du marché
Les livraisons de médicaments sans aiguille se font sous forme de sprays puissants, d'injecteurs à jet, et de patchs cutanés. La technologie sans aiguille réduit les inquiétudes des patients concernant l’utilisation d’aiguilles. Les dispositifs sans aiguille sont des injections efficaces pour une large gamme de médicaments et sont bioéquivalents aux aiguilles. Les avantages des dispositifs d'administration sans aiguille incluent moins de douleur, une injection rapide, aucun problème d'élimination des aiguilles et peuvent être auto-administrés. Ainsi, les avantages des dispositifs d'administration de médicaments sans aiguille par rapport aux aiguilles et seringues conventionnelles sont principalement responsables de la demande croissante de dispositifs d'administration de médicaments sans aiguille.
Stratégique Insights
Moteurs et opportunités du marché des dispositifs d'administration de médicaments sans aiguille
Prévalence croissante des maladies chroniques et des troubles du mode de vie pour favoriser le marché
Les maladies chroniques telles que les maladies cardiaques, le diabète et le cancer sont les principales causes de décès et d'invalidité dans le monde. Selon les Centers for Disease Control and Prevention (CDC), environ 38,4 millions de personnes aux États-Unis souffraient de diabète en 2021. Pour contrôler l'incidence du diabète, l'insuline est injectée à travers la couche sous-cutanée à intervalles réguliers. En raison de l’augmentation de la prévalence du diabète, la demande d’injections d’insuline augmente également. Les entreprises se concentrent sur le développement de dispositifs à insuline sans aiguille pour éviter les blessures par piqûre d’aiguille. Par exemple, Medicsen se concentre sur le développement de SmartPatch pour administrer une insuline plus efficace.
Préférence croissante pour les soins de santé à domicile - Une opportunité pour le marché de l'administration de médicaments sans aiguille< /span>
Le passage des hôpitaux, des établissements de longue durée, des établissements de réadaptation pour patients hospitalisés et des établissements de soins infirmiers qualifiés aux établissements de soins à domicile se traduit par de plus grandes chances d'une interaction meilleure, cohérente et opportune entre patient et médecin en raison de l’utilisation croissante du cloud et des dispositifs médicaux basés sur la mobilité. Dans les pays en développement, le nombre de patients recevant une thérapie à domicile a été limité dans le passé. Les patchs intelligents et les injecteurs à jet sont intégrés au (DSE), ce qui permet aux médecins de surveiller le dosage n'importe où. À l’aide de dispositifs d’administration de médicaments sans aiguille, le patient peut facilement s’auto-administrer ses médicaments conformément aux exigences prescrites par le médecin. Ainsi, l’accent accru mis sur les soins de santé à domicile et l’utilisation de produits technologiquement intégrés devrait constituer une opportunité de croissance du marché au cours de la période de prévision.
Dispositifs d'administration de médicaments sans aiguille Analyse de segmentation du rapport de marché
Segments clés qui ont contribué à l'élaboration des dispositifs d'administration de médicaments sans aiguille Les analyses de marché sont le type et l'application.
- En fonction du type, le Le marché des dispositifs d’administration de médicaments sans aiguille est segmenté en inhalateurs, injecteurs à jet, nouvelles aiguilles, patchs transdermiques et autres. Le segment des injecteurs à jet détenait la plus grande part de marché en 2023.
- Par application, le marché est segmenté en administration d'insuline, vaccination, gestion de la douleur et autres. Le segment des maladies liées à l'administration d'insuline a dominé le marché en 2023.
Dispositifs d'administration de médicaments sans aiguille Analyse de la part de marché par géographie
La portée géographique du rapport sur le marché des dispositifs d'administration de médicaments sans aiguille est principalement segmentée en cinq régions : Amérique du Nord, Asie-Pacifique, Europe, Moyen-Orient et Europe. Afrique et Amérique du Sud.
L'Amérique du Nord a dominé le marché des dispositifs d'administration de médicaments sans aiguille en 2023. La croissance du marché en Amérique du Nord est caractérisée par une demande accrue de médicaments contre les maladies rares provenant de sociétés biopharmaceutiques et biotechnologiques, la présence d'acteurs clés du marché, une augmentation des lancements de produits, une augmentation du fardeau des blessures par piqûre d'aiguille et une recherche et développement approfondie menée par des instituts universitaires et de recherche et des sociétés pharmaceutiques et biotechnologiques. De plus, l’Asie-Pacifique devrait enregistrer le TCAC le plus élevé dans les années à venir.
Actualités et développements récents du marché des dispositifs d’administration de médicaments sans aiguille
< p>Le marché des dispositifs d'administration de médicaments sans aiguille est évalué en collectant des données qualitatives et quantitatives après des recherches primaires et secondaires, qui comprennent d'importantes publications d'entreprise, des données d'association et des bases de données. Voici une liste des développements sur le marché des dispositifs d'administration de médicaments sans aiguille et des stratégies :- < li>NovaXS, qui a été créée à l'Université de Californie à Berkeley, a conçu sa technologie Telosis en attente de brevet pour administrer un flux étroit de médicaments sans aiguille en 0,3 seconde et pour analyser les données d'injection afin de permettre des décisions de santé plus intelligentes. (Source : NovaXS BIotech, communiqué de presse, 2022)
- NuGen Medical Devices Inc. a lancé les appareils InsuJet au Canada. SOL-MILLENNIUM Medical Group s'est inscrit comme exposant à la conférence professionnelle 2022 de Diabète Canada/Société canadienne d'endocrinologie et métabolisme (CSEM), où il a lancé le produit InsuJet pour le Canada. (Source : NuGen Medical Devices Inc, site Web de l'entreprise, 2022)
Dispositifs d'administration de médicaments sans aiguille Couverture et livrables du rapport de marché< /h3>
Le « Dispositifs d'administration de médicaments sans aiguille Taille et prévisions du marché (2023-2031) » le rapport fournit une analyse détaillée du marché couvrant les domaines ci-dessous :
- Taille et prévisions du marché aux niveaux mondial, régional et national pour tous les marchés clés segments couverts par le champ d'application
- Dynamique du marché, telles que les moteurs, les contraintes et les opportunités clés
- Principales tendances futures
- Détaillé Analyse PEST et SWOT
- Analyse du marché mondial et régional couvrant les principales tendances du marché, les principaux acteurs, les réglementations et les développements récents du marché
- Analyse du paysage industriel et de la concurrence couvrant le marché concentration, analyse de la carte thermique, acteurs importants et développements récents
- Profils détaillés des entreprises
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Needle-free drug deliveries are taken in the form of power sprays, jet injectors, inhalers, and skin patches. Needle-free technology reduces patient concern about using needles. Needle-free devices are effective injections for a wide range of drugs and are bioequivalent to needles. Advantages of needle-free delivery devices include less pain, fast injection, no needle disposal issue, and can be self-administered. Thus, the benefits of needle-free drug delivery devices over conventional needles and syringes are mainly responsible for the increasing demand for needle-free drug delivery devices.
Increasing prevalence of chronic diseases and increasing needlestick injuries propels the needle-free drug delivery devices market growth. However, the high cost of development as compare to injections hinders the growth of the market.
The needle-free drug delivery device market majorly consists of the players such NuGen Medical Devices Inc, NovaXS Biotech, GlaxoSmithKline, AstraZeneca, Roche, Boehringer Ingelheim, Merck, Cipla, Novartis, Teva Pharmaceuticals, Omron Healthcare, Sumitomo Pharma Co., Ltd
Based on type, the needle-free drug delivery devices market is segmented into inhalers, jet injectors, novel needles, transdermal patches, and others.
By application, the market is segmented into insulin delivery, vaccination, pain management, and others. The insulin delivery disease segment dominated the market in 2023.
Based on geography, the needle-free drug delivery device market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). North America is the largest contributor to the growth of the global needle-free drug delivery device market. Asia Pacific is expected to register the highest CAGR in the needle-free drug delivery device market during 2022–2030.
The List of Companies - Needle-Free Drug Delivery Devices Market
- NuGen Medical Devices Inc
- NovaXS Biotech
- GlaxoSmithKline
- AstraZeneca
- Roche
- Boehringer Ingelheim
- Merck
- Cipla
- Novartis
- Teva Pharmaceuticals
- Omron Healthcare
- Sumitomo Pharma Co., Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Apr 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Apr 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)